Journal issues > Issue 8, December 2022 > Congress highlights ISHL12

Congress highlights ISHL12

By: J. Blokken PhD, PharmD, T. Feys MBA, MSc

SUMMARY

The 12^th International Symposium on Hodgkin Lymphoma (ISHL12) took place as a hybrid conference in Cologne, Germany, from October 22 to 24, 2022. During the conference, ISHL12 provided a comprehensive overview of the latest advances in biology, clinical research, diagnostics and treatment of Hodgkin Lymphoma. The main focus was on older and frail patients as well as on patients with early stage disease. Several workshops, interactive case discussions and satellite symposia complemented the program.

(BELG J HEMATOL 2022;13(8):328–32)

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top